|
Search
Collections
Benchmarks
Upload document
Product
One dose group
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
COVID-19
Clinical trial
A Randomized, Blinded, Positive-controlled Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001 in Population Aged 18 Years and Above（Negative for Antibody Against COVID-19）
Status: Withdrawn
, Estimated PCD: 2023-06-27
